Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
HEK293T cells were seeded in 6-well plates and transfected with 0.5 g NLuc--arrestin-2-CyOFP under a TK promoter, 0.5 g SNAP-GLP-1R under a CMV promoter, plus 1 g pcDNA3.1, for 24 hours before the assay
Providing your location allows us to show you nearby locations and doctors
ATTAIN-1 (NCT05869903) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron at various doses to placebo in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes
Nutrition Considerations for Weight Loss Medication Jan 26, 2026 5-8 min read Weight-loss medications, including semaglutide (Wegovy, Ozempic), liraglutide (Saxenda, Victoza), and dual-acting tirzepatide (Zepbound, Mounjaro), are increasingly used as tools for managing health
Pentavitin gives you long-lasting hydration 3
Please contact your local recycling facility to ensure recyclability
